AN UNPUBLISHED AMENHOTEP-III FAIENCE PLAQUE FROM MYCENAE

被引：10
作者：
CLINE, E
机构：
来源：
JOURNAL OF THE AMERICAN ORIENTAL SOCIETY | 1990年 / 110卷 / 02期
关键词：
D O I：
10.2307/604526
中图分类号：
C [社会科学总论];
学科分类号：
03 ; 0303 ;
摘要：
引用
收藏
页码：200 / 212
页数：13
相关论文
共 50 条
  • [41] Efficacy and safety of efalizumab in a large cohort of patients with moderate to severe plaque psoriasis: Pooled results from randomized phase III trials
    Gordon, K
    Pariser, D
    Langley, R
    Caro, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P1 - P1
  • [42] Impact of Calcified Plaque on Vascular Remodeling After Bioresorbable Vascular Scaffold Implantation; Insights From the ABSORB III and ABSORB Japan Trials
    Imura, Shinji
    Nishi, Takeshi
    Okada, Kozo
    Kitahara, Hideki
    Kameda, Ryo
    Ikutomi, Masayasu
    Hollak, Brooke
    Yock, Paul G.
    Popma, Jeffrey J.
    Kusano, Hajime
    Cheong, Wai-Fung
    Sudhir, Krishna
    Fitzgerald, Peter
    Ellis, Stephen G.
    Kereiakes, Dean
    Stone, Gregg W.
    Honda, Yasuhiro
    Kimura, Takeshi
    CIRCULATION, 2019, 140
  • [43] POPULATION PHARMACOKINETICS OF RISANKIZUMAB IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: ANALYSES INCLUDING THE DATA FROM PHASE III CLINICAL TRIALS.
    Suleiman, A. A.
    Khatri, A.
    Minocha, M.
    Othman, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S44 - S44
  • [44] Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials
    Kokolakis, Georgios
    Warren, Richard B.
    Strober, Bruce
    Blauvelt, Andrew
    Puig, Luis
    Morita, Akimichi
    Gooderham, Melinda
    Koerber, Andreas
    Vanvoorden, Veerle
    Wang, Maggie
    de Cuyper, Dirk
    Madden, Cynthia
    Gomez, Natalie Nunez
    Lebwohl, Mark
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (03) : 330 - 340
  • [45] Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis
    Revicki, Dennis A.
    Willian, Mary Kaye
    Menter, Alan
    Gordon, Kenneth B.
    Kimball, Alexa B.
    Leonardi, Craig L.
    Langley, Richard G.
    Kimel, Miriam
    Okun, Martin
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (06) : 341 - 350
  • [46] Secukinumab efficacy and safety in Asian subjects with moderate to severe plaque psoriasis: Pooled analysis from the FIXTURE and ERASURE phase III clinical studies
    Lee, Jeung-Hoon
    Morita, Akimichi
    Tsai, Tsen-Fang
    Zheng, Eugene
    Ko, Luke
    Fox, Todd
    Langley, Richard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB249 - AB249
  • [47] Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled Trial
    David, Michael
    Gospodinov, Dimitar Konstantinov
    Gheorghe, Nicola
    Mateev, Grisha Stefanov
    Rusinova, MariyanaVenelinova
    Hristakieva, Evgeniya
    Solovastru, Laura Gheuca
    Patel, Rita. V.
    Giurcaneanu, Calin
    Hitova, Mariela Chepileva
    Purcaru, Anca Ioana
    Horia, Beti
    Tsingov, Iliya Iliev
    Yankova, Rumyana Kaloferova
    Kadurina, Miroslava Ilieva
    Ramon, Michael
    Rotaru, Maria
    Simionescu, Olga
    Benea, Vasile
    Demerdjieva, Zdravka Velichkova
    Cosgarea, Maria Rodica
    Morariu, Horia Silviu
    Michael, Ziv
    Cristodor, Patricia
    Nica, Carmen
    Silverman, Michael H.
    Bristol, David R.
    Harpaz, Zivit
    Farbstein, Motti
    Cohen, Shira
    Fishman, Pnina
    JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (08) : 931 - 938
  • [48] Treatment of plaque-type psoriasis with oral CF101: Data from a phase II/III phase 2 clinical trial
    Gospodinov, Dimitar
    Mateev, Grisha
    Gheorghe, Nicola
    Hristakieva, Evgeniya
    Purcaru, Anca
    Rusinova, Mariyana
    Tsingov, Iliya
    Solovastru, Laura
    Yankova, Rumyana
    David, Michael
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB279 - AB279
  • [49] From vulnerable plaque to vulnerable patient - Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) task force report
    Naghavi, Morteza
    Falk, Erling
    Hecht, Harvey S.
    Jamieson, Michael J.
    Kaul, Sanjay
    Berman, Daniel
    Fayad, Zahi
    Budoff, Matthew J.
    Rumberger, John
    Naqvi, Tasneem Z.
    Shaw, Leslee J.
    Faergeman, Ole
    Cohn, Jay
    Bahr, Raymond
    Koenig, Wolfgang
    Demirovic, Jasenka
    Arking, Dan
    Herrera, Victoria L. M.
    Badimon, Juan
    Goldstein, James A.
    Rudy, Yoram
    Airaksinen, Juhani
    Schwartz, Robert S.
    Riley, Ward A.
    Mendes, Robert A.
    Douglas, Pamela
    Shah, Prediman K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (2A) : 2H - 15H
  • [50] Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study
    Asahina, Akihiko
    Nakagawa, Hidemi
    Etoh, Takafumi
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2010, 37 (04) : 299 - 310
12345